Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2585 (LINC02585)

Target
LINC02585
Molecular classification
Long intergenic non-coding RNA, Long non-coding RNA (lncRNA)
01

Overview

Long intergenic non-protein coding RNA 2585 (LINC02585) is a long non-coding RNA, more specifically a long intergenic non-coding RNA, identified in the human genome. Like other lincRNAs, it is a non-protein-coding transcript longer than 200 nucleotides that does not overlap with protein-coding genomic regions[1][3][7]. LincRNAs as a class are known to regulate gene expression through diverse mechanisms, including chromatin remodeling, transcriptional regulation, and influencing RNA stability or translation, often in a tissue-specific manner[7]. LINC02585 is also known by the alias CELSR3-AS1[3]. There is currently no direct evidence that LINC02585 functions as a therapeutic target, interacts with drugs, or is used as a biomarker. While many lincRNAs play important roles in disease processes, such as cancer, specific functional or disease associations for LINC02585 have not yet been reported in the literature. The general study and annotation of lincRNAs such as LINC02585 are expanding knowledge of non-coding genomic regions in molecular biology and disease[7].

Other names
CELSR3-AS1
02

Mechanism of action

Not applicable; not an established drug target

03

Biological functions

Chromatin remodelingRNA stabilizationTranscription regulationPossible enhancer activity and fine-tuned gene expression
04

Disease associations

No direct evidence associating LINC02585 itself with a specific disease in current search results (other lincRNAs may be involved in cancer, but none for LINC02585)By analogy, several lincRNAs are implicated in cancer and tumor biology

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2585 (LINC02585).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2585 (LINC02585).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call